115 related articles for article (PubMed ID: 22154743)
1. A dimerized single-chain variable fragment system for the assessment of neutralizing activity of phage display-selected antibody fragments specific for cytomegalovirus.
Carlsson F; Trilling M; Perez F; Ohlin M
J Immunol Methods; 2012 Feb; 376(1-2):69-78. PubMed ID: 22154743
[TBL] [Abstract][Full Text] [Related]
2. [Human anti-HCMV neutralizing Fab antibody generated by phage display library].
Duan T; Liang MF; Gu SY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):247-50. PubMed ID: 15340569
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations.
Planitzer CB; Saemann MD; Gajek H; Farcet MR; Kreil TR
Transplantation; 2011 Aug; 92(3):267-70. PubMed ID: 21659947
[TBL] [Abstract][Full Text] [Related]
4. The neutralizing human recombinant antibodies to pathogenic Orthopoxviruses derived from a phage display immune library.
Tikunova N; Dubrovskaya V; Morozova V; Yun T; Khlusevich Y; Bormotov N; Laman A; Brovko F; Shvalov A; Belanov E
Virus Res; 2012 Jan; 163(1):141-50. PubMed ID: 21964238
[TBL] [Abstract][Full Text] [Related]
5. Single chain variable fragment antibodies against Shiga toxins isolated from a human antibody phage display library.
Neri P; Shigemori N; Hamada-Tsutsumi S; Tsukamoto K; Arimitsu H; Shimizu T; Akahori Y; Kurosawa Y; Tsuji T
Vaccine; 2011 Jul; 29(33):5340-6. PubMed ID: 21664401
[TBL] [Abstract][Full Text] [Related]
6. Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates.
Mussi-Pinhata MM; Pinto PC; Yamamoto AY; Berencsi K; de Souza CB; Andrea M; Duarte G; Jorge SM
J Med Virol; 2003 Feb; 69(2):232-9. PubMed ID: 12683413
[TBL] [Abstract][Full Text] [Related]
7. Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients.
Iizuka A; Komiyama M; Tai S; Oshita C; Kurusu A; Kume A; Ozawa K; Nakamura Y; Ashizawa T; Yamamoto A; Yamazaki N; Yoshikawa S; Kiyohara Y; Yamaguchi K; Akiyama Y
Immunol Lett; 2011 Mar; 135(1-2):64-73. PubMed ID: 20932861
[TBL] [Abstract][Full Text] [Related]
8. A new look at a poorly immunogenic neutralization epitope on cytomegalovirus glycoprotein B. Is there cause for antigen redesign?
Ohlin M
Mol Immunol; 2014 Aug; 60(2):95-102. PubMed ID: 24802891
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between the kinetics of human cytomegalovirus (HCMV) glycoprotein B (gB)-specific and neutralizing serum antibodies and development or recovery from HCMV active infection in patients undergoing allogeneic stem cell transplant.
Muñoz I; Gutiérrez A; Gimeno C; Farga A; Alberola J; Solano C; Prósper F; García-Conde J; Navarro D
J Med Virol; 2001 Sep; 65(1):77-84. PubMed ID: 11505447
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to the major linear neutralizing domains of cytomegalovirus glycoprotein B among natural seropositives and CMV subunit vaccine recipients.
Marshall GS; Li M; Stout GG; Louthan MV; Duliège AM; Burke RL; Hunt LA
Viral Immunol; 2000; 13(3):329-41. PubMed ID: 11016597
[TBL] [Abstract][Full Text] [Related]
11. A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).
Adler SP; Plotkin SA; Gonczol E; Cadoz M; Meric C; Wang JB; Dellamonica P; Best AM; Zahradnik J; Pincus S; Berencsi K; Cox WI; Gyulai Z
J Infect Dis; 1999 Sep; 180(3):843-6. PubMed ID: 10438376
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing antibodies are unable to inhibit direct viral cell-to-cell spread of human cytomegalovirus.
Jacob CL; Lamorte L; Sepulveda E; Lorenz IC; Gauthier A; Franti M
Virology; 2013 Sep; 444(1-2):140-7. PubMed ID: 23849792
[TBL] [Abstract][Full Text] [Related]
13. Binding and neutralizing anti-cytomegalovirus activities in immune globulin products.
Wang X; Xu Y; Scott DE; Murata H; Struble EB
Biologicals; 2017 Nov; 50():35-41. PubMed ID: 29029807
[TBL] [Abstract][Full Text] [Related]
14. Analysis of SIVmac Envelope-Specific Antibodies Selected Through Phage Display.
Ita S; Agostinho MR; Sullivan K; Yub Han S; Akleh R; Johnson WE; Fofana IBF
AIDS Res Hum Retroviruses; 2017 Aug; 33(8):869-879. PubMed ID: 28075174
[TBL] [Abstract][Full Text] [Related]
15. [Construction of phage display antibody library to MCF-7 cells and screening of single-chain antibodies against breast cancer cells].
Zhao Y; Wang QM; Fu XQ; Chen JZ; Fan GC; Chen HP
Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):667-72. PubMed ID: 15973987
[TBL] [Abstract][Full Text] [Related]
16. Functional Properties of Human Cytomegalovirus Hyperimmunoglobulin and Standard Immunoglobulin Preparations.
Germer M; Herbener P; Schüttrumpf J
Ann Transplant; 2016 Sep; 21():558-64. PubMed ID: 27595792
[TBL] [Abstract][Full Text] [Related]
17. Lack of antibodies against the antigen domain 2 epitope of cytomegalovirus (CMV) glycoprotein B is associated with CMV disease after renal transplantation in recipients having the same glycoprotein H serotypes as their donors.
Ishibashi K; Tokumoto T; Shirakawa H; Hashimoto K; Ikuta K; Kushida N; Yanagida T; Shishido K; Aikawa K; Toma H; Inoue N; Yamaguchi O; Tanabe K; Suzutani T
Transpl Infect Dis; 2011 Jun; 13(3):318-23. PubMed ID: 20804536
[TBL] [Abstract][Full Text] [Related]
18. Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins.
Chehimi J; Peppard J; Emanuel D
Bone Marrow Transplant; 1987 Dec; 2(4):395-402. PubMed ID: 2844341
[TBL] [Abstract][Full Text] [Related]
19. Molecular dissection of the human B cell response against cytomegalovirus infection by lambda display.
Beghetto E; Paolis FD; Spadoni A; Del Porto P; Buffolano W; Gargano N
J Virol Methods; 2008 Jul; 151(1):7-14. PubMed ID: 18499273
[TBL] [Abstract][Full Text] [Related]
20. Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.
Gardner TJ; Bolovan-Fritts C; Teng MW; Redmann V; Kraus TA; Sperling R; Moran T; Britt W; Weinberger LS; Tortorella D
Clin Vaccine Immunol; 2013 Apr; 20(4):540-50. PubMed ID: 23389931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
